Tarek Elbeik
- Virology top 0.2%
- Infectious Diseases top 1%
- Immunology top 5%
- Epidemiology top 5%
- Molecular Biology
- Co-authors
- Robert M. GrantMark B. FeinbergPedro BarbosaSteven G. DeeksRichard LoftusFrederick HechtSilvija I. StapransSusan Buchbinder
- Topics
- HIV Research and Treatment (33 papers)HIV/AIDS drug development and treatment (22 papers)HIV/AIDS Research and Interventions (18 papers)
- Journals
- New England Journal of MedicineThe Journal of Experimental MedicineAnnals of Internal Medicine
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Tarek Elbeik
42 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 99
- Virology 1.8k
- Infectious Diseases 1.4k
- Immunology 660
- Epidemiology 652
- Molecular Biology 255
Countries citing papers authored by Tarek Elbeik
This map shows the geographic impact of Tarek Elbeik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Elbeik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Elbeik more than expected).
Fields of papers citing papers by Tarek Elbeik
This network shows the impact of papers produced by Tarek Elbeik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Elbeik. The network helps show where Tarek Elbeik may publish in the future.
Co-authorship network of co-authors of Tarek Elbeik
This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Elbeik. A scholar is included among the top collaborators of Tarek Elbeik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Elbeik. Tarek Elbeik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 11 | |
| 5 | 44 | |
| 6 | 52 | |
| 7 | PERFORMANCE OF THE NEW VIROSEQ ™ HIV-1 GENOTYPING SYSTEM (VERSION 2) WITH GROUP M SUBTYPE PANEL AND WITH SUBTYPE B CLINICAL RESEARCH SAMPLES AT TEST SITES | 3 |
| 8 | 23 | |
| 9 | 354 | |
| 10 | 76 | |
| 11 | 22 | |
| 12 | 38 | |
| 13 | 272 | |
| 14 | 393 | |
| 15 | 1 | |
| 16 | 249 | |
| 17 | 20 | |
| 18 | 2 | |
| 19 | 23 | |
| 20 | 2 |
About Tarek Elbeik
Tarek Elbeik is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 43 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (33 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (18 papers). The work is most often cited by research in Virology (1.8k citations), Infectious Diseases (1.4k citations) and Immunology (660 citations). Tarek Elbeik has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert M. Grant, Mark B. Feinberg, Pedro Barbosa, Steven G. Deeks, Richard Loftus, Frederick Hecht, Silvija I. Staprans, Susan Buchbinder, Melinda Swanson and Spyros A. Kalams. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.